Searched for
COVOVAX
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseThe move comes after a letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) to the Union health ministry on ...- Serum Institute seeks inclusion of Covovax on CoWIN as heterologous booster dose for adultsLast month, COVID-19 Working Group headed by Dr N K Arora had also recommended to the health ministry inclusion of Covovax on the CoWIN por...
- NTAGI panel takes up inclusion of Covid jab COVOVAX on CoWIN portalThe DCGI had approved Covovax for restricted use in emergency situations in adults on December 28, 2021, in the 12-17 age group on March 9,...
- DGCI approves Covid-19 vaccine Covovax as heterologous booster dose"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab ...
- Govt panel recommends market authorisation for Covovax jab as heterologous booster dosePrakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...
- SII gets govt nod to export 32.4 lakh doses of Covovax vaccine to USIn a letter to the government on June 29, Prakash Kumar Singh, director (government and regulatory affairs) at SII had sought permission to...
- NTAGI panel recommends inclusion of Covovax in vaccination drive for 12-17 age group"The COVID-19 working group of the NTAGI (National Technical Advisory Group on Immunisation) had earlier reviewed data related to Covovax a...
- SII's Adar Poonawalla says Covovax first Indian COVID vaccine to be sold in EuropePoonawalla, in an exclusive interview with ANI, said, "We have a stockpile of 200 million doses of Covishield...We've already exported 40 m...
- Govt panel recommends inclusion of Covovax in national Covid vaccination drive for those aged 12 and aboveThe COVID-19 Working Group has now recommended to the Standing Technical Sub-Committee of the National Technical Advisory Group on Immunisa...
- NTAGI's Covid working group to review SII's Covovax data for use in 12 year olds and aboveIndia's drug regulator had approved Covovax for restricted use in emergency situations in adults on December 28 and in the 12 to 17 years a...
- India's drugs regulator gives nod to phase-3 clinical trial of Covid vaccine CovovaxCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- Serum Institute seeks Covovax's inclusion in Covid vaccination drive for 12 years and aboveIndia's drug regulator had granted restricted emergency use authorisation to Covovax for the 12 to 17 years age group subject to certain co...
- Govt panel recommends EUA for Covid vaccine Covovax for 12-17 age groupThe Drugs Controller General of India (DCGI) had approved Covovax for restricted use in emergency situation in adults on December 28. It ha...
- SII seeks permission for phase-3 study of Covid vaccine Covovax as booster dose in adultsCovovax is manufactured by technology transfer from Novavax and is approved by the European Medicines Agency for conditional marketing auth...
- SII set to export 25 crore Covovax doses for Covax from next monthIndia's drug regulator had on December 28 granted emergency use authorisation (EUA) to Covovax. However, with the government not planning t...
- Covovax approval to strengthen immunization efforts in India, lower and middle income countries, says SIIHe was responding to Union Health Minister Mansukh Mandaviya's announcement that the Central Drug Authority, the Central Drugs Standard Con...
- CDSCO panel recommends emergency use authorisation for SII's Covid vaccine Covovax"The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) reviewed the emergency use autho...
- WHO nod boosts Covovax chances of getting approval in IndiaCovovax is being manufactured in India by the Serum Institute of India (SII).
- Covovax nod expected by January, data to be submitted soon, says SII ChiefThe drug regulator had earlier asked the company - which had applied for emergency use authorisation (SII) for Covovax in August - to submi...
- SII aims to launch Covovax by September as US eases suppliesThe Pune-based vaccine maker has received the first lot of supplies of key raw materials for Covovax production, company insiders told ET. ...
Load More
